Immunoterapia Z Użyciem Przeciwciał Monoklonalnych Ukierunkowanych Na Szlak PD-1/PD-L1 W Chorobach Nowotworowych

Acta Haematologica Polonica - Poland
doi 10.2478/ahp-2018-0025
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Obraz Hemoreologiczny W Chorobach Nowotworowych

Letters in Oncology Science
2019English

Macrophage PD-L1 Strikes Back: PD-1/PD-L1 Interaction Drives Macrophages Toward Regulatory Subsets

Advances in Bioscience and Biotechnology
2013English

Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy

Oncolytic Virotherapy
2018English

High-Affinity PD-1 Molecules Deliver Improved Interaction With PD-L1 and PD-L2

Cancer Science
Cancer ResearchMedicineOncology
2018English

PD-1 Receptor (PDCD1; PD-1; CD279); Programmed Cell Death 1 Ligand 1 (CD274 Molecule; PD-L1; B7-H1)

Science-Business eXchange
2010English

The Immunoinhibitory PD-1/PD-L1 Pathway in Inflammatory Blood Vessel Disease

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2017English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment

Clinical and Experimental Immunology
AllergyImmunology
2019English

PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy